Drug reference
Tuberculosis resistant to first-line drugs, in combination with other drugs ▶BY DEEP INTRAMUSCULAR INJECTION ▶Adult: 1 g daily (max. per dose 20 mg/kg) for 2–4 months, then reduced to 1 g 2–3 times a week
PDF page 641
Auditory impairment
PDF page 641
→Appendix 1: capreomycin
PDF page 641
Eosinophilia. febrile disorders. hearing impairment. leucocytosis. leucopenia. nephrotoxicity. pain. pseudo-Bartter syndrome. skin reactions. thrombocytopenia. tinnitus. vertigo
PDF page 641
Manufacturer advises use only if potential benefit outweighs risk—teratogenic in animal studies.
PDF page 641
Manufacturer advises caution—no information available.
PDF page 641
Nephrotoxic; ototoxic. Dose adjustments Reduce dose—consult product literature.
PDF page 641
Monitor renal, hepatic, auditory, and vestibular function and electrolytes.
PDF page 641
There can be variation in the licensing of different medicines containing the same drug. Powder for solution for injection ▶Capreomycin (Non-proprietary) Capreomycin (as Capreomycin sulfate) 1 gram Capreomycin 1g powder for solution for injection vials | 1 vial P £31.47
PDF page 641
1 g daily (max. per dose 20 mg/kg) for
First-line fragment. Read the complete Indications and Dose section above.
PDF page 641
